Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y. Wen, Donald A. Berry, Meredith Buxton, Howard Colman et autres
us, ca, ch (code pays fourni par la source)
9 citations
Journal of Clinical Oncology